Emerging Diseases News

Cases of multisystem inflammatory syndrome in children increased by nearly two-thirds last fall, aligning with an increase in COVID-19 activity, according to a study published in MMWR.

DENVER — Among people with HIV, hybrid immunity against COVID-19 is more effective at preventing infection and severe disease than vaccination alone, according to a study.

Personalized care could help patients and providers plan safe returns to work or school from respiratory illnesses, according to a research review.

A potential threat on the CDC’s radar is a fungal infection being transmitted by feral cats — initially in Brazil, but now in other countries as well.

Continuous Medicaid eligibility during COVID-19 significantly reduced postpartum loss of insurance, but was not tied to health care use, contraceptive use, breastfeeding or depressive symptoms in early postpartum, researchers reported.

Zika virus is an important mosquito-borne pathogen with significant public health concerns. Zika vaccine development is an ongoing area of research with several candidates in the pipeline.

COVID-19 vaccination availability was not associated with changes in abnormal uterine bleeding incidence for women of reproductive age, researchers reported in the American Journal of Obstetrics and Gynecology.

Approximately 25% of patients with COVID-19 who are immunocompromised remain positive for the disease 21 days or more from initial onset, according to data published in The Lancet Microbe.

Patients with a history of COVID-19 demonstrate a higher risk for new-onset autoimmune inflammatory rheumatic diseases, with greater infection severity linked to greater risk, according to data published in the Annals of Internal Medicine.

DENVER — SARS-CoV-2 antigens persist in patients with COVID-19 for months to years after infection, according to data presented at the Conference on Retroviruses and Opportunistic Infections.